| Dec 17 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 6.81M |
| Gross Profit | $ -131.00K |
| Operating Income | $ -6.48M |
| EBITDA | $ -6.19M |
| Net Income | $ -6.81M |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 490.00K |
| Total Assets | $ 15.96M |
| Total Debt | $ 5.39M |
| Net Debt | $ 4.90M |
| Total Liabilities | $ 10.18M |
| Stockholders' Equity | $ 5.78M |
| Cash Flow | |
| Free Cash Flow | $ -2.72M |
| Operating Cash Flow | $ -2.58M |
| Investing Cash Flow | $ -134.00K |
| Financing Cash Flow | $ 3.88M |
Medite Cancer Diagnostics Inc (MDIT)
OTHER OTC:MDIT
